Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Credo Biomedical is looking for series B investment to further the development its lead diagnostic product.
Brazilian company NGS Genomics Solutions is looking for funding to develop its next-generation sequencing technology.
Animal Pharm is seeking new authors for its animal health industry reports team.
Animart has evolved its veterinary medication business into "an integrated animal health company" through a merger with fellow US firm Animal Profiling.
US genetic analyzer specialist LexaGene has secured more positive results from a pilot clinical study focused on detecting canine urinary tract infections.
Zoetis has gone from a couple of exploratory acquisitions to being a key market player in veterinary diagnostics, according to executive vice president Clint Lewis. Animal Pharm editor Joseph Harvey got the lowdown from Mr Lewis on this relatively new but burgeoning area for Zoetis, while analyst Sian Lazell listened to his opening keynote speech at the recent Animal Health Investment Europe conference in London.
Zomedica Pharmaceuticals' net loss doubled in 2018 on the back of a heavy R&D focus throughout the year.
US veterinary diagnostics firm Heska posted a 5.5% fall in sales during the fourth quarter of 2018.
Boehringer Ingelheim Animal Health is to work with Germany's GNA Biosolutions to develop emergency veterinary diagnostics.
US firm Thermo Fisher Scientific has launched a new porcine reproductive and respiratory syndrome (PRRS) test kit for pigs.
US firm LexaGene claims its rapid canine pathogen detection technology can highlight the presence of antibiotic resistance factors.
Netherlands-headquartered firm BioChek has introduced a new porcine respiratory reproductive syndrome (PRRS) test kit to its portfolio.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.